These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12699252)

  • 1. Simple, reliable and fast spectrofluorometric method for determination of plasma Verteporfin (Visudyne) levels during photodynamic therapy for choroidal neovascularization.
    Aquaron R; Forzano O; Murati JL; Fayet G; Aquaron C; Ridings B
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):925-30. PubMed ID: 12699252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verteporfin ocular photodynamic therapy.
    Bakri SJ; Kaiser PK
    Expert Opin Pharmacother; 2004 Jan; 5(1):195-203. PubMed ID: 14680447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
    Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
    Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization.
    Husain D; Miller JW; Michaud N; Connolly E; Flotte TJ; Gragoudas ES
    Arch Ophthalmol; 1996 Aug; 114(8):978-85. PubMed ID: 8694734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.
    Kramer M; Miller JW; Michaud N; Moulton RS; Hasan T; Flotte TJ; Gragoudas ES
    Ophthalmology; 1996 Mar; 103(3):427-38. PubMed ID: 8600419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].
    Chen YX; Ge J; Yan M; Jin CJ; Zhang MX; Dong FT; Lu F; Zhang CF; Zhao JL
    Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin.
    Miller JW; Walsh AW; Kramer M; Hasan T; Michaud N; Flotte TJ; Haimovici R; Gragoudas ES
    Arch Ophthalmol; 1995 Jun; 113(6):810-8. PubMed ID: 7540388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy with verteporfin: a new treatment in ophthalmology.
    Michels S; Schmidt-Erfurth U
    Semin Ophthalmol; 2001 Dec; 16(4):201-6. PubMed ID: 15513441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
    Bressler NM;
    Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
    Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC;
    Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
    Hariprasad SM; Shah GK
    Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of skin photosensitivity and incidence of photosensitivity reactions after administration of verteporfin.
    Houle JM; Strong HA
    Retina; 2002 Dec; 22(6):691-7. PubMed ID: 12476093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verteporfin.
    Scott LJ; Goa KL
    Drugs Aging; 2000 Feb; 16(2):139-46; discussion 147-8. PubMed ID: 10755329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Photodynamic therapy in age-related macular degeneration--results of one year observation].
    Wykrota H; Gierek-Łapińska A
    Klin Oczna; 2002; 104(3-4):239-43. PubMed ID: 12608309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of verteporfin.
    Houle JM; Strong A
    J Clin Pharmacol; 2002 May; 42(5):547-57. PubMed ID: 12017349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.
    Schmidt-Erfurth UM; Michels S
    Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining photodynamic therapy and feeder vessel photocoagulation: a pilot study.
    Staurenghi G; Massacesi A; Musicco I; Salvetti P; Viola F
    Semin Ophthalmol; 2001 Dec; 16(4):233-6. PubMed ID: 15513446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of verteporfin pharmakokinetics--redefining the need of photosensitizers in ophthalmology.
    Ziemssen F; Heimann H
    Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):1023-41. PubMed ID: 22762303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.